Histone modifications and their role in epigenetics of atopy and allergic diseases

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Bilal Alaskhar Alhamwe - , University Hospital Gießen and Marburg (Author)
  • Razi Khalaila - , University Hospital Gießen and Marburg (Author)
  • Johanna Wolf - , University Hospital Gießen and Marburg (Author)
  • Verena von Bülow - , University Hospital Gießen and Marburg (Author)
  • Hani Harb - , University Hospital Gießen and Marburg, Worldwide Universities Network (WUN), German Center for Lung Research (DZL) (Author)
  • Fahd Alhamdan - , University Hospital Gießen and Marburg (Author)
  • Charles S Hii - , Women and Children's Hospital Campus (Author)
  • Susan L Prescott - , inVIVO Planetary Health (Author)
  • Antonio Ferrante - , inVIVO Planetary Health (Author)
  • Harald Renz - , University Hospital Gießen and Marburg (Author)
  • Holger Garn - , University Hospital Gießen and Marburg (Author)
  • Daniel P Potaczek - , University Hospital Gießen and Marburg (Author)

Abstract

This review covers basic aspects of histone modification and the role of posttranslational histone modifications in the development of allergic diseases, including the immune mechanisms underlying this development. Together with DNA methylation, histone modifications (including histone acetylation, methylation, phosphorylation, ubiquitination, etc.) represent the classical epigenetic mechanisms. However, much less attention has been given to histone modifications than to DNA methylation in the context of allergy. A systematic review of the literature was undertaken to provide an unbiased and comprehensive update on the involvement of histone modifications in allergy and the mechanisms underlying this development. In addition to covering the growing interest in the contribution of histone modifications in regulating the development of allergic diseases, this review summarizes some of the evidence supporting this contribution. There are at least two levels at which the role of histone modifications is manifested. One is the regulation of cells that contribute to the allergic inflammation (T cells and macrophages) and those that participate in airway remodeling [(myo-) fibroblasts]. The other is the direct association between histone modifications and allergic phenotypes. Inhibitors of histone-modifying enzymes may potentially be used as anti-allergic drugs. Furthermore, epigenetic patterns may provide novel tools in the diagnosis of allergic disorders.

Details

Original languageEnglish
Article number39
JournalAllergy, Asthma and Clinical Immunology
Volume14
Publication statusPublished - 2018
Peer-reviewedYes
Externally publishedYes

External IDs

PubMedCentral PMC5966915
Scopus 85047484264

Keywords